Marcel Conrad, MD
Medical Oncologist
Conditions Treated
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
specialties & services
Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy Targeted Therapy
Hospitals & Clinics
Bio & Insurance Information
Education & Training
Georgetown University School of Medicine
Medical School
Walter Reed Army Medical Center
Internship
Walter Reed Army Medical Center
Residency
Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
Medical License
AL State Medical License Active through 2013
Hospitals & Clinics
Publications
Dr. Marcel Conrad has contributed to 3 publications.
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study.
Whitehead, R.P., McCoy, S., Rivkin, S.E., Gross, H.M., Conrad, M.E., Doolittle, G.C., Wolff, R.A., Goodwin, J.W., Dakhil, S.R., Abbruzzese, J.L.; Invest New Drugs. 2006 Nov.
See more >>Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study.
Lavey, R.S., Liu, P.Y., Greer, B.E., Robinson, W.R., Chang, P.C., Wynn, R.B., Conrad, M.E., Jiang, C., Markman, M., Alberts, D.S.; Gynecol Oncol. 2004 Oct.
See more >>Localization of the iron transport proteins Mobilferrin and DMT-1 in the duodenum: the surprising role of mucin.
Simovich, M., Hainsworth, L.N., Fields, P.A., Umbreit, J.N., Conrad, M.E.; Am J Hematol. 2003 Sep.
See more >>